Gene: DNAAF11
Official Full Name: dynein axonemal assembly factor 11provided by HGNC
Gene Summary: The protein encoded by this gene contains several leucine-rich repeat domains and appears to be involved in the motility of cilia. Defects in this gene are a cause of primary ciliary dyskinesia-19 (CILD19). Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 4, 11 and 22. [provided by RefSeq, Apr 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18240 | DNAAF11 Knockout cell line (HeLa) | Human | DNAAF11 | 1:3~1:6 | Negative | Online Inquiry |
KO18241 | DNAAF11 Knockout cell line (HCT 116) | Human | DNAAF11 | 1:2~1:4 | Negative | Online Inquiry |
KO18242 | DNAAF11 Knockout cell line (HEK293) | Human | DNAAF11 | 1:3~1:6 | Negative | Online Inquiry |
KO18243 | DNAAF11 Knockout cell line (A549) | Human | DNAAF11 | 1:3~1:4 | Negative | Online Inquiry |
DNAAF11 Gene Knockout Cell Lines are uniquely developed cellular models that provide researchers with invaluable tools for the functional analysis of the DNAAF11 gene. DNAAF11, or "Defined Nod-like Receptor and ATRX-associated Factor 11," is pivotal in cellular processes such as ciliary assembly and related signaling pathways. This knockout model effectively disables the DNAAF11 gene, enabling scientists to observe the downstream effects that gene disruption has on cellular behavior and function.
The primary mechanism of action involves CRISPR/Cas9 gene-editing technology, which introduces precise mutations within the DNAAF11 locus, resulting in a non-functional gene product. Researchers can utilize these knockout cell lines to dissect the role of DNAAF11 in various biological contexts, particularly in diseases where ciliary dysfunction is implicated, such as polycystic kidney disease and certain types of respiratory disorders. The insights gained from these experiments are crucial in advancing our understanding of ciliary dynamics and pathophysiology.
In terms of scientific importance, DNAAF11 Gene Knockout Cell Lines stand out by facilitating targeted studies that are often difficult to achieve with conventional methods. This model provides a dynamic system for screening potential therapeutic compounds and for elucidating pathways that influence cilia-related diseases, thus bridging gaps in our knowledge for both basic and translational research.
Compared to alternative knockout systems, such as those derived from less stable or less relevant cell backgrounds, these specialized lines offer enhanced reliability and reproducibility. They are rigorously validated to ensure consistent phenotypic expression and functional behavior, making them essential tools for precise experimental outcomes.
For researchers and clinicians focused on genetic and molecular studies, the DNAAF11 Gene Knockout Cell Lines represent a powerful asset. Their ability to provide deeper insights into disease mechanisms and facilitate the development of targeted therapies will be invaluable in their ongoing work.
At our company, we pride ourselves on our innovative approach to biological research, constantly striving to supply the scientific community with cutting-edge tools and models that drive discovery and enhance understanding in genetic research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.